“…In addition to ErbB3 and ErbB4 (12, 61), Nrdp1 has been reported to promote the ubiquitination and degradation of a diverse array of proteins involved in cellular regulation, including several type 1 cytokine receptors (62–64), the Toll-like receptor signaling adapter protein MyD88 (65), the inhibitor of apoptosis domain–containing protein BRUCE (66), the nuclear factors retinoic acid receptor (62) and C/EBPb (67), and the E3 ubiquitin ligase Parkin (68). Moreover, as a regulator of the stability of key signaling proteins, Nrdp1 could play roles in the onset or progression of various disease states that involve ER and cellular stresses, including breast cancer (38, 69, 70), prostate cancer (60, 71), colorectal cancer (72–74), glioblastoma (75, 76), cardiac disease (77, 78), Parkinson’s disease (68), and diabetes (59, 79).…”